Non-insulin oral drug(s)-Glucophage (Metformin) - Page 2 of 4 Posts on Medivizor
Navigation Menu

Non-insulin oral drug(s)-Glucophage (Metformin) Posts on Medivizor

Searching for patients with type 2 diabetes to test the effectiveness of the drug semaglutide compared to other standard treatments

Posted by on Dec 15, 2018 in Diabetes mellitus | 0 comments

In a nutshell The aim of this study is to test the effectiveness of semaglutide (Ozempic) in the treatment of type 2 diabetes compared to other currently used treatments. The main outcome to be measured is the change in HbA1c (blood test measuring blood sugar control over 3 months). This study is being conducted in the United States. The details...

Read More

Looking for young people with type 2 diabetes to try dapagliflozin and saxagliptin

Posted by on Aug 31, 2018 in Diabetes mellitus | 0 comments

In a nutshell This phase 3 clinical trial is investigating the safety and effectiveness of dapagliflozin (Forxiga) and saxagliptin (Onglyza) in young people with type 2 diabetes (T2D). The main outcome to be measured will be change in HbA1c (measures average blood glucose over the last 3 months) after 6 months of treatment. The details Dapagliflozin...

Read More

Investigating a combination of ertugliflozin and sitagliptin in people with type 2 diabetes

Posted by on Jan 26, 2018 in Diabetes mellitus | 0 comments

In a nutshell This study investigated the effectiveness and safety of ertugliflozin (Steglatro) plus sitagliptin (Januvia), compared to either drug used alone, in people with type 2 diabetes (T2D). It was determined that the combination was better at controlling blood glucose levels, without increasing the risk of side effects. Some background...

Read More

Does autoinjected exenatide suspension improve blood glucose control in patients with type 2 diabetes on metformin therapy?

Posted by on Aug 26, 2017 in Diabetes mellitus | 0 comments

In a nutshell This study assessed the safety and effectiveness of a new formulation of exenatide compared to sitaglipitin in patients with sub-optimal blood sugar control taking metformin. This study concluded that exenatide reduced blood sugar levels over 3 months more effectively than sitaglipitin.  Some background There are many blood...

Read More

Can a multivitamin prevent vitamin B-12 deficiency caused by metformin?

Posted by on Aug 29, 2016 in Diabetes mellitus | 0 comments

In a nutshell This study aimed to determine the relationship between metformin (Glucophage) use in older adults with diabetes and vitamin B-12 concentrations, and assess whether B-12 supplementation can alter this. Metformin use was shown to be linked to lower B-12 levels, and multivitamin use may be protective against this.  Some background...

Read More

New: Effectiveness of lixisenatide does not depend on beta-cell function in type 2 diabetes

Posted by on Aug 1, 2016 in Diabetes mellitus | 0 comments

In a nutshell This study examined whether lixisenatide (Adlyxin) was effective in patients with differing levels of beta cell function (the cells that produce insulin). The authors found that lixisenatide decreased blood glucose (blood sugar) levels regardless of beta cell function. Some background Type 2 diabetes (T2D) is a progressive disease....

Read More

How effective are once weekly GLP-1 receptor agonists for the treatment of type 2 diabetes?

Posted by on Jan 25, 2016 in Diabetes mellitus | 0 comments

In a nutshell This review examined the safety and effectiveness of once weekly GLP-1 receptor agonists for the treatment of type 2 diabetes. The authors concluded that once weekly  GLP-1 RA drugs are convenient, safe and effective for the treatment of type 2 diabetes. Some background Patients with type 2 diabetes (T2D) initially produce...

Read More